Kelsey KT - Search Results

1

Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United States.

Schned AR, Andrew AS, Marsit CJ, Kelsey KT, Zens MS, Karagas MR. Schned AR, et al. Among authors: kelsey kt. Scand J Urol Nephrol. 2008;42(3):237-42. doi: 10.1080/00365590801948166. Scand J Urol Nephrol. 2008. PMID: 18432530 Free PMC article.

2

Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer.

Nelson HH, Kelsey KT, Bronson MH, Mott LA, Karagas MR. Nelson HH, et al. Among authors: kelsey kt. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):809-10. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11440968 No abstract available.

3

The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction.

Nelson HH, Kelsey KT, Mott LA, Karagas MR. Nelson HH, et al. Among authors: kelsey kt. Cancer Res. 2002 Jan 1;62(1):152-5. Cancer Res. 2002. PMID: 11782372

4

Microsatellite instability at tetranucleotide repeats in skin and bladder cancer.

Danaee H, Nelson HH, Karagas MR, Schned AR, Ashok TD, Hirao T, Perry AE, Kelsey KT. Danaee H, et al. Among authors: kelsey kt. Oncogene. 2002 Jul 25;21(32):4894-9. doi: 10.1038/sj.onc.1205619. Oncogene. 2002. PMID: 12118368

5

Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival.

Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Marsit CJ, et al. Among authors: kelsey kt. Oncogene. 2004 Jan 29;23(4):1000-4. doi: 10.1038/sj.onc.1207256. Oncogene. 2004. PMID: 14647419

6

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.

Kelsey KT, Hirao T, Schned A, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR. Kelsey KT, et al. Br J Cancer. 2004 Apr 19;90(8):1572-6. doi: 10.1038/sj.bjc.6601748. Br J Cancer. 2004. PMID: 15083187 Free PMC article.

7

A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer.

Kelsey KT, Park S, Nelson HH, Karagas MR. Kelsey KT, et al. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1337-41. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298955

8

Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence.

Marsit CJ, Kim DH, Liu M, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: kelsey kt. Int J Cancer. 2005 Mar 20;114(2):219-23. doi: 10.1002/ijc.20714. Int J Cancer. 2005. PMID: 15540210

9

Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.

Marsit CJ, Hasegawa M, Hirao T, Kim DH, Aldape K, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: kelsey kt. Cancer Res. 2004 Dec 1;64(23):8702-7. doi: 10.1158/0008-5472.CAN-04-2558. Cancer Res. 2004. PMID: 15574780

10

Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.

Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT. Karagas MR, et al. Among authors: kelsey kt. Cancer Lett. 2005 Feb 28;219(1):63-9. doi: 10.1016/j.canlet.2004.10.006. Cancer Lett. 2005. PMID: 15694665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters